Table 1 Characteristics of colorectal carcinoma patients and prognostic effect on DFS and OVS.
From: Humoral immune response to MUC5AC in patients with colorectal polyps and colorectal carcinoma
| Â | Number | (%) | DFS (months) | P value | OVS (months) | P value |
|---|---|---|---|---|---|---|
Age | Â | Â | Â | Â | Â | Â |
   60≤ | 17 | 56.7 | 10.5 | 0.0184 | 34 | 0.216 |
   >60 | 13 | 43.3 | 18.9 |  | 48.4 |  |
Sex | Â | Â | Â | Â | Â | Â |
   Female | 12 | 40 | 18.2 | 0.221 | 42.2 | 0.782 |
   Male | 18 | 60 | 11.5 |  | 39 |  |
Tumor location | Â | Â | Â | Â | Â | Â |
   Colon | 24 | 80 | 10.1 | 0.0272 | 34.8 | 0.0111 |
   Rectum | 6 | 20 | 30.3 |  | 62 |  |
Dukes Stage | Â | Â | Â | Â | Â | Â |
   A | - |  |  |  |  |  |
   B | 8 | 26.7 | 25.7 | 0.0002 | 50.2 | 0.0076 |
   C | 11 | 36.7 | 17.8 |  | 48.4 |  |
   D | 11 | 36.7 | 2.18 |  | 24.9 |  |
Histologic type | Â | Â | Â | Â | Â | Â |
   Adeno Ca | 27 | 90 | 14.92 | 0.455 | 42.55 | 0.0243 |
   Mucinous Ca | 1 | 3.3 | 10.0 |  | 13.0 |  |
   Adenosquamous Ca | 1 | 3.3 | 13.0 |  | 27.0 |  |
   Adenocarcinoid Ca | 1 | 3.3 | 0.0 |  | 20.0 |  |
Differentiation | Â | Â | Â | Â | Â | Â |
   Well differentiated | 6 | 20 | 8.3 | 0.0407 | 46.3 | 0.002 |
   Moderately differentiated | 19 | 63.3 | 18.6 |  | 43.9 |  |
   Poorly differentiated | 4 | 13.3 | 5.5 |  | 21.7 |  |
   Colloid (mucinous) | 1 | 3.3 | 0.0 |  | 9 |  |
Metastatic Lymph Node | Â | Â | Â | Â | Â | Â |
   Absent | 8 | 26.7 | 25.7 | 0.0398 | 50.25 | 0.259 |
   Present | 22 | 73.3 | 10.0 |  | 36.68 |  |
Preoperative Metastasis | Â | Â | Â | Â | Â | Â |
   Absent | 19 | 64.3 | 21.1 | 0.000 | 49 | 0.0018 |
   Present | 11 | 36.6 | 2.18 |  | 24.91 |  |
Serum MUC5AC Ab level | Â | Â | Â | Â | Â | Â |
   Negative | 12 | 40 | 19.91 | 0.153 | 50.0 | 0.052 |
   Positive | 18 | 60 | 10.38 |  | 33.83 |  |